| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/26/2004 | US20040167324 Method for isolating and purifying nucleic acids |
| 08/26/2004 | US20040167317 for treating lymphocyte-related disorders using self-assembling molecular complex designated pre-pro-B cell growth stimulating factor (PPBSF); genetic engineering |
| 08/26/2004 | US20040167090 Covalent modification of RNA for in vitro and in vivo delivery |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167088 Method of using adenoviral vectors with increased persistence in vivo |
| 08/26/2004 | US20040167087 Complexing of rna with hydrophilic polymer; stabilization |
| 08/26/2004 | US20040167075 Diagnosis, therapy od Alzheimer's disease; blocking psychological conditions |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040167070 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 08/26/2004 | US20040167066 Cleavage and polyadenylation complex of precursor mrna |
| 08/26/2004 | US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases |
| 08/26/2004 | US20040166580 Vector constructs |
| 08/26/2004 | US20040166575 Inosine producing bacterium belonging to the genus Bacillus and method for producing inosine |
| 08/26/2004 | US20040166573 replicon RNAs are electroporated into permissive cells and are harvested from the surfaces of the cells using a salt wash in which the salt concentration is from about 0.2 to about 5 M sodium/calcium/magnesium/potassium chloride |
| 08/26/2004 | US20040166570 Genes involved in polysaccharide production and utilization thereof |
| 08/26/2004 | US20040166567 for producing libraries for drug screening polyketide compounds; genetic engineering |
| 08/26/2004 | US20040166566 Novel promoter |
| 08/26/2004 | US20040166565 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 08/26/2004 | US20040166564 D-aminoacylase and gene encoding the same |
| 08/26/2004 | US20040166563 used for transformation efficiency, to stimulate plant cell growth, including stem cells, organogenesis, and somatic embryogenesis, and to induce apomixis; genetic engineering |
| 08/26/2004 | US20040166561 Novel intein and uses thereof |
| 08/26/2004 | US20040166560 Expression of recombinant proteinase k <I> from tritirachium album </I>in yeast |
| 08/26/2004 | US20040166559 Vectors for gene therapy |
| 08/26/2004 | US20040166558 Novel protein-deamidating enzyme, gene encoding the same, production process therefor, and use thereof |
| 08/26/2004 | US20040166553 Caged sensors, regulators and compounds and uses thereof |
| 08/26/2004 | US20040166545 for drug screening using newly designed vectors coding for marker proteins and transfected cells; for high throughput assays |
| 08/26/2004 | US20040166544 Antibodies to c-Met for the treatment of cancers |
| 08/26/2004 | US20040166543 Regulation of cell growth by MUC1 |
| 08/26/2004 | US20040166538 Multimeric protein comprising ligand binding domain for use in identifying modulator associated with ligand/receptor binding activity; detecting posttranslational modification-dependent polypeptide associations; drug screening |
| 08/26/2004 | US20040166533 Optimization of synthetic catalysts by means of directed evolution |
| 08/26/2004 | US20040166529 Comprises electrophoretic tag (e-tag) probes for the multiplexed detection of binding or interactions between one or more ligands and target antiligands; biomolecular marker and signal resolution |
| 08/26/2004 | US20040166528 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 08/26/2004 | US20040166526 Gene cloning |
| 08/26/2004 | US20040166524 Method and device for purifying nucleic acids |
| 08/26/2004 | US20040166522 Microarray, method for producing the same, and method for correcting inter-PIN spotting amount error of the same |
| 08/26/2004 | US20040166516 Providing a candidate catalytic protein fusion molecule, including a catalytic protein linked to both its nucleic acid coding sequence and a substrate; determining whether candidate catalytic protein catalyzes a reaction of the substrate by assaying for an alteration in molecular size, charge etc. |
| 08/26/2004 | US20040166512 Method for cloning PCR products without restriction or ligation enzymes |
| 08/26/2004 | US20040166500 Comprises nucleotide sequences coding encoding secretory polypeptides that contain signal peptides and/or transmembrane domains for use in diagnostic assays and toxicity testing |
| 08/26/2004 | US20040166499 Nucleotide sequence polulation for priming, binding or annealing single strand polynucleotide and allowing the synthesis of a second polynucleotide complementary strand; microarray/biochip preparation |
| 08/26/2004 | US20040166497 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/26/2004 | US20040166486 RNA three dimensional structure (pseudoknot) which stimulates/activates protein synthesis; enhancement of cell-free translation of heterologous polypeptides |
| 08/26/2004 | US20040166225 A Brassica seed oil, having a stearic acid content of about 15% to about 30% and a polyunsaturated fatty acid content of about 2% to about 15% |
| 08/26/2004 | US20040166141 Methods and devices for modulating the immune response |
| 08/26/2004 | US20040166121 Viricides from transgenic plant; dna sequences codes gene expression on surface of antigen ; insertion of nucleotide sequence into plant; genetic engineering |
| 08/26/2004 | US20040166116 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 08/26/2004 | US20040166110 For multiple drug resistance cancer; purification of hemoatopoietic stem cells; diagnosis, therapy |
| 08/26/2004 | US20040166109 Modulator polypeptide for regulation of intracellular endocytosis of amyloid precursor proteins; diagnosis and treatment of neurodegenerative disorders |
| 08/26/2004 | US20040166105 Compositions and methods relating to breast specific genes and proteins |
| 08/26/2004 | US20040166099 Molecules preferentially associated with effector T cells and methods of their use |
| 08/26/2004 | US20040166098 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 08/26/2004 | US20040166092 Use of viral vectors and charged molecules for gene therapy |
| 08/26/2004 | US20040166091 Materials and methods for treating disorders of the ear |
| 08/26/2004 | US20040166061 drug screening for antidiabetic or antiobesity agents by determining whether a test compound activates expression of the human transcription factor gene FKHL14/FOXC2, winged helix protein; using mouse model of obesity to test the potential drug |
| 08/26/2004 | US20040166026 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 08/26/2004 | DE10305774A1 Verfahren zur fermentativen Herstellung von L-Methionin A process for the fermentative preparation of L-methionine |
| 08/26/2004 | CA2791225A1 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex |
| 08/26/2004 | CA2556351A1 Antimicrobial agents from streptococcus mitis and streptococcus oralis |
| 08/26/2004 | CA2516236A1 Antibodies to c-met for the treatment of cancers |
| 08/26/2004 | CA2515699A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | CA2515688A1 Sirna libraries optimized for predetermined protein families |
| 08/26/2004 | CA2515684A1 Altered fad2 and fad3 genes in brassica and the molecular marker-assisted detection thereof |
| 08/26/2004 | CA2515474A1 Antibody molecules having specificity for human il-1.beta. |
| 08/26/2004 | CA2515213A1 Stimuli-responsive polymer conjugates and related methods |
| 08/26/2004 | CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | CA2515203A1 Immunocompromised rodents as dual color tumor models |
| 08/26/2004 | CA2515200A1 Galacturonosyltransferases, nucleic acids encoding same and uses therefor |
| 08/26/2004 | CA2515108A1 Directed genetic modifications of human stem cells |
| 08/26/2004 | CA2515039A1 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/26/2004 | CA2514912A1 Rnai targeting of viruses |
| 08/26/2004 | CA2513668A1 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 08/26/2004 | CA2512644A1 Gene resistant to aphis gossypii |
| 08/26/2004 | CA2512589A1 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 08/26/2004 | CA2512588A1 Annexin promoter and its use in expression of transgenic genes in plants |
| 08/25/2004 | EP1449925A1 Method of diagnosis of type 2 diabetes |
| 08/25/2004 | EP1449924A1 PROCESS FOR PRODUCING AlPHA1,4-GALACTOSYLTRANSFERASE AND GALACTOSE-CONTAINING COMPLEX SUGAR |
| 08/25/2004 | EP1449923A1 Novel formate dehydrogenase tolerant to halogen compounds and process for producing the same |
| 08/25/2004 | EP1449922A2 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 08/25/2004 | EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449913A1 Gamma-glutamylcysteine-producing yeast |
| 08/25/2004 | EP1449850A1 Human cdr-grafted antibodies and antibody fragments thereof |
| 08/25/2004 | EP1449849A2 Protease-resistant thrombomodulin analog |
| 08/25/2004 | EP1449848A1 Method for the production of cystine-knot proteins |
| 08/25/2004 | EP1449537A2 Methods for treating hypercoagulable states or acquired protein C deficiency |
| 08/25/2004 | EP1449432A1 Nonhuman model animal of systemic lupus erythematosus |
| 08/25/2004 | EP1449431A1 Sgrf genetically modified nonhuman animal |
| 08/25/2004 | EP1449218A2 Molehole embedded 3-d crossbar architecture used in electrochemical molecular memory device |
| 08/25/2004 | EP1448986A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 08/25/2004 | EP1448984A2 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 08/25/2004 | EP1448799A2 Compositions and methods of selective nucleic acid isolation |
| 08/25/2004 | EP1448797A1 Method and kit for detection of novel pathogen inhibitors |
| 08/25/2004 | EP1448795A1 Hybridization portion control oligonucleotide and its uses |
| 08/25/2004 | EP1448794A2 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 08/25/2004 | EP1448793A1 Annealing control primer and its uses |
| 08/25/2004 | EP1448782A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors |
| 08/25/2004 | EP1448781A2 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells |
| 08/25/2004 | EP1448780A2 Direct targeting binding proteins |
| 08/25/2004 | EP1448779A1 Genes coding for glucose-6-phosphate-dehydrogenase proteins |
| 08/25/2004 | EP1448777A2 Method for genetic transformation of woody trees |
| 08/25/2004 | EP1448776A1 Method for the isolation of nucleic acids |